Market Overview:
The global glabridin market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for glabridin in cosmetic and pharmaceutical applications. Glabridin is a major component of licorice extract and exhibits various pharmacological properties, such as anti-inflammatory, antioxidant, and skin whitening effects. These properties are driving its demand in the cosmetic industry. In addition, it also has several therapeutic benefits such as relief from gastritis symptoms, peptic ulcers, diarrhea, and other gastrointestinal problems which is fueling its demand in the pharmaceutical industry. However, stringent regulatory norms for product approvals are restraining the growth of this market. On the basis of type, HPLC accounted for a major share of the global glabridin market in 2017 owing to its high purity levels (98%). Other types include 20%, 40%, 60%, 90%, and 98%. On the basis of application, cosmetics held a dominant share in 2017 followed by pharmaceuticals. The growing awareness about personal care among consumers coupled with rising income levels is propellingthe demand for cosmetics products containing glabridin across regions.
Product Definition:
Glabridin is a flavonoid present in licorice extract. It has been shown to possess anti-inflammatory and antioxidative properties.
20% (HPLC):
20% (HPLC) is a water-soluble, highly potent, and bioactive form of Glabridin. It’s an active ingredient extracted from the leaves of Western Australia's native plant species, Pelargonium occidentale.
40% (HPLC):
40% (HPLC) is a water-based liquid chromatography mobile phase with the ability to separate and detect molecules based on their molecular weight. It has been used as a standard solvent in the quantification of glabridin, which is an active ingredient in herbal supplements such as ginseng, milk thistle and other plant extracts.
40% (HPLC) can be used for both qualitative.
Application Insights:
The cosmetic application segment led the global glabridin market in 2017 and is projected to witness significant growth over the forecast period. The product has anti-aging properties which help improve skin texture and minimize wrinkles. It also helps reduce hyperpigmentation, discoloration, and scarring caused due to UV damage. In addition, it helps prevent skin aging due to its high antioxidant content that neutralizes free radicals present in the body that cause damage to cells. These benefits are expected drive demand from various end-use industries such as pharmaceuticals & cosmetics over the coming years.
Regional Analysis:
North America was the largest regional market in 2017 owing to growing consumer awareness regarding skin aging and its associated problems. The region is expected to maintain its dominance over the forecast period due to increasing R&D activities for new product development coupled with rising adoption of advanced cosmetic products. Europe also held a significant share of global revenue in 2017, majorly driven by countries such as Germany, U.K., France, Italy, and Spain among others where high concentration of cosmetics companies are located.
Asia Pacific is projected to be one of the fastest-growing regions during the forecast period owing to developing economies such as China.
Growth Factors:
- Increasing demand for natural ingredients in cosmetics and personal care products
- Rising awareness about the benefits of glabridin for skin health
- Growing popularity of Asian skincare regimens that emphasize the use of herbal ingredients
- Innovation in glabridin-based cosmetic formulations
- Expansion of distribution channels for glabridin-based cosmeceuticals
Scope Of The Report
Report Attributes
Report Details
Report Title
Glabridin Market Research Report
By Type
20% (HPLC), 40% (HPLC), 60% (HPLC), 90% (HPLC), 98% (HPLC), Other
By Application
Cosmetic, Pharmaceutical
By Companies
Sabinsa, Alchem International, MAFCO, Plamed Green Science Group, Xi'an Zhongying, Spring Autumn Biological, Huaian Brothers Biotechnology, Xi’an Tianye Biotech, Maruzen Pharmaceuticals, SK Bioland, Sunpure Extracts
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
197
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global Glabridin Market Report Segments:
The global Glabridin market is segmented on the basis of:
Types
20% (HPLC), 40% (HPLC), 60% (HPLC), 90% (HPLC), 98% (HPLC), Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cosmetic, Pharmaceutical
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sabinsa
- Alchem International
- MAFCO
- Plamed Green Science Group
- Xi'an Zhongying
- Spring Autumn Biological
- Huaian Brothers Biotechnology
- Xi’an Tianye Biotech
- Maruzen Pharmaceuticals
- SK Bioland
- Sunpure Extracts
Highlights of The Glabridin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 20% (HPLC)
- 40% (HPLC)
- 60% (HPLC)
- 90% (HPLC)
- 98% (HPLC)
- Other
- By Application:
- Cosmetic
- Pharmaceutical
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Glabridin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Glabridin is a flavonoid found in various plants. It has anti-inflammatory and antioxidant properties.
Some of the major players in the glabridin market are Sabinsa, Alchem International, MAFCO, Plamed Green Science Group, Xi'an Zhongying, Spring Autumn Biological, Huaian Brothers Biotechnology, Xi’an Tianye Biotech, Maruzen Pharmaceuticals, SK Bioland, Sunpure Extracts.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Glabridin Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Glabridin Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Glabridin Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Glabridin Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Glabridin Market Size & Forecast, 2020-2028
4.5.1 Glabridin Market Size and Y-o-Y Growth
4.5.2 Glabridin Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 20% (HPLC)
5.2.2 40% (HPLC)
5.2.3 60% (HPLC)
5.2.4 90% (HPLC)
5.2.5 98% (HPLC)
5.2.6 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Cosmetic
6.2.2 Pharmaceutical
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Glabridin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Glabridin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 20% (HPLC)
9.6.2 40% (HPLC)
9.6.3 60% (HPLC)
9.6.4 90% (HPLC)
9.6.5 98% (HPLC)
9.6.6 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Cosmetic
9.10.2 Pharmaceutical
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 20% (HPLC)
10.6.2 40% (HPLC)
10.6.3 60% (HPLC)
10.6.4 90% (HPLC)
10.6.5 98% (HPLC)
10.6.6 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Cosmetic
10.10.2 Pharmaceutical
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 20% (HPLC)
11.6.2 40% (HPLC)
11.6.3 60% (HPLC)
11.6.4 90% (HPLC)
11.6.5 98% (HPLC)
11.6.6 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Cosmetic
11.10.2 Pharmaceutical
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 20% (HPLC)
12.6.2 40% (HPLC)
12.6.3 60% (HPLC)
12.6.4 90% (HPLC)
12.6.5 98% (HPLC)
12.6.6 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Cosmetic
12.10.2 Pharmaceutical
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 20% (HPLC)
13.6.2 40% (HPLC)
13.6.3 60% (HPLC)
13.6.4 90% (HPLC)
13.6.5 98% (HPLC)
13.6.6 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Cosmetic
13.10.2 Pharmaceutical
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Glabridin Market: Competitive Dashboard
14.2 Global Glabridin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sabinsa
14.3.2 Alchem International
14.3.3 MAFCO
14.3.4 Plamed Green Science Group
14.3.5 Xi'an Zhongying
14.3.6 Spring Autumn Biological
14.3.7 Huaian Brothers Biotechnology
14.3.8 Xi’an Tianye Biotech
14.3.9 Maruzen Pharmaceuticals
14.3.10 SK Bioland
14.3.11 Sunpure Extracts
